(September 2008)
ISSN 0007-0920
Welcome to BJC
Multidisciplinary Journal of Cancer Research
BJC publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients.
BJC is proud of its editorial independence, high standards, and tradition of serving the international cancer research community - we are one of the world's leading general cancer journals.
Impact factor 4.635
Archive
Coinciding with the release of the first issue of Volume 99 of BJC on 1st July 2008, and the launch of our new website design, BJC, NPG and Cancer Research UK are pleased to announce that all BJC papers will become freely available to readers of this website, 12 months after they are published.
This applies in the first instance to papers published in and after 1999. Please see our Archive page for the details.
Web Focus: New targets for cancer therapy
Showcasing some of the most cited recent minireviews, this new collection focuses on key pathways and targets for new therapeutics, including the IGF pathway, rapamycin and mTOR signalling, the EGFR pathway, epigenetics and microRNAs. Click here to view the minireviews collection.
Featured Articles
Role of LKB1 in lung cancer development
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer
Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis
Survival from cancer in teenagers and young adults in England, 1979–2003
Lung cancer screening: the way forward
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3
